[1]
Y. HARAHAP, B. P. MAGGADANI, T. R. J. SITORUS, C. A. MULYADI, and D. J. PURWANTO, “CLINICAL APPLICATION OF DRIED BLOOD SPOT FOR MONITORING STUDIES OF TAMOXIFEN, ENDOXIFEN, AND 4-HYDROXYTAMOXIFEN IN BREAST CANCER PATIENT USING LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY”, Int J App Pharm, vol. 11, no. 2, pp. 59-63, Jan. 2019.